SORT1 and hepatocellular carcinoma: To comprehensively assess the role of SORT1 in HCC progression in vivo, we used both subcutaneous xenograft and orthotopic HCC mouse models to compare the development and progression of HCC in the SORT1-silenced (siSORT1) and negative control (NC) groups.